|
1
|
Medical Research Council Oesophageal
Cancer Working Group. Surgical resection with or without
preoperative chemotherapy in oesophageal cancer: a randomised
controlled trial. Lancet. 359:1727–1733. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kelsen DP, Ginsberg R, Pajak TF, Sheahan
DG, Gunderson L, Mortimer J, Estes N, Haller DG, Ajani J, Kocha W,
et al: Chemotherapy followed by surgery compared with surgery alone
for localized esophageal cancer. N Engl J Med. 339:1979–1984. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gebski V, Burmeister B, Smithers BM, Foo
K, Zalcberg J and Simes J: Australasian Gastro-Intestinal Trials
Group, Survival benefits from neoadjuvant chemoradiotherapy or
chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet
Oncol. 8:226–234. 2007. View Article : Google Scholar
|
|
4
|
Law S, Fok M, Chow S, Chu KM and Wong J:
Preoperative chemotherapy versus surgical therapy alone for
squamous cell carcinoma of the esophagus: a prospective randomized
trial. J Thorac Cardiovasc Surg. 114:210–217. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ando N, Iizuka T, Ide H, Ishida K, Shinoda
M, Nishimaki T, Takiyama W, Watanabe H, Isono K, Aoyama N, et al:
Japan Clinical Oncology Group, Surgery plus chemotherapy compared
with surgery alone for localized squamous cell carcinoma of the
thoracic esophagus: a Japan Clinical Oncology Group Study -
JCOG9204. J Clin Oncol. 21:4592–4596. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yano M, Takachi K, Doki Y, Miyashiro I,
Kishi K, Noura S, Eguchi H, Yamada T, Ohue M, Ohigashi H, et al:
Preoperative chemotherapy for clinically node-positive patients
with squamous cell carcinoma of the esophagus. Dis Esophagus.
19:158–163. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tepper J, Krasna MJ, Niedzwiecki D, Hollis
D, Reed CE, Goldberg R, Kiel K, Willett C, Sugarbaker D and Mayer
R: Phase III trial of trimodality therapy with cisplatin,
fluorouracil, radiotherapy, and surgery compared with surgery alone
for esophageal cancer: CALGB 9781. J Clin Oncol. 26:1086–1092.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hilgenberg AD, Carey RW, Wilkins EW Jr,
Choi NC, Mathisen DJ and Grillo HC: Preoperative chemotherapy,
surgical resection, and selective postoperative therapy for
squamous cell carcinoma of the esophagus. Ann Thorac Surg.
45:357–363. 1998. View Article : Google Scholar
|
|
9
|
Ancona E, Ruol A, Santi S, Merigliano S,
Sileni VC, Koussis H, Zaninotto G, Bonavina L and Peracchia A: Only
pathologic complete response to neoadjuvant chemotherapy improves
significantly the long term survival of patients with resectable
esophageal squamous cell carcinoma: final report of a randomized,
controlled trial of preoperative chemotherapy versus surgery alone.
Cancer. 191:2165–2174. 2001.
|
|
10
|
Urschel JD, Vasan H and Blewett CJ: A
meta-analysis of randomized controlled trials that compared
neoadjuvant chemotherapy and surgery to surgery alone for
resectable esophageal cancer. Am J Surg. 183:274–279. 2002.
View Article : Google Scholar
|
|
11
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zeisberg EM, Tarnavski O, Zeisberg M,
Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT,
Roberts AB, et al: Endothelial-to-mesenchymal transition
contributes to cardiac fibrosis. Nat Med. 13:952–961. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zeisberg M, Yang C, Martino M, Duncan MB,
Rieder F, Tanjore H and Kalluri R: Fibroblasts derive from
hepatocytes in liver fibrosis via epithelial to mesenchymal
transition. J Biol Chem. 282:23337–23347. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim KK, Kugler MC, Wolters PJ, Robillard
L, Galvez MG, Brumwell AN, Sheppard D and Chapman HA: Alveolar
epithelial cell mesenchymal transition develops in vivo during
pulmonary fibrosis and is regulated by the extracellular matrix.
Proc Natl Acad Sci USA. 103:13180–13185. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: at the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Biddle A, Liang X, Gammon L, Fazil B,
Harper LJ, Emich H, Costea DE and Mackenzie IC: Cancer stem cells
in squamous cell carcinoma switch between two distinct phenotypes
that are preferentially migratory or proliferative. Cancer Res.
71:5317–5326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kurrey NK, Jalgaonkar SP, Joglekar AV,
Ghanate AD, Chaskar PD, Doiphode RY and Bapat SA: Snail and slug
mediate radioresistance and chemoresistance by antagonizing
p53-mediated apoptosis and acquiring a stem-like phenotype in
ovarian cancer cells. Stem Cells. 27:2059–2068. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Eyler CE and Rich JN: Survival of the
fittest: cancer stem cells in therapeutic resistance and
angiogenesis. J Clin Oncol. 26:2839–2845. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Baumann M, Krause M and Hill R: Exploring
the role of cancer stem cells in radioresistance. Nat Rev Cancer.
8:545–554. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Miyata H, Yoshioka A, Yamasaki M,
Nushijima Y, Takiguchi S, Fujiwara Y, Nishida T, Mano M, Mori M and
Doki Y: Tumor budding in tumor invasive front predicts prognosis
and survival of patients with esophageal squamous cell carcinomas
receiving neoadjuvant chemotherapy. Cancer. 115:3324–3334. 2009.
View Article : Google Scholar
|
|
23
|
Usami Y, Chiba H, Nakayama F, Ueda J,
Matsuda Y, Sawada N, Komori T, Ito A and Yokozaki H: Reduced
expression of claudin-7 correlates with invasion and metastasis in
squamous cell carcinoma of the esophagus. Hum Pathol. 37:569–577.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miller AB, Hoogstraten B, Staquet M and
Winkler A: Reporting results of cancer treatment. Cancer.
47:207–214. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Japan Esophageal Society. Japanese
classification of esophageal cancer, tenth edition: parts II and
III. Esophagus. 6:71–94. 2009. View Article : Google Scholar
|
|
26
|
Lombaerts M, van Wezel T, Philippo K,
Dierssen JW, Zimmerman RM, Oosting J, van Eijk R, Eilers PH, van de
Water B, Cornelisse CJ and Cleton-Jansen AM: E-cadherin
transcriptional downregulation by promoter methylation but not
mutation is related to epithelial-to-mesenchymal transition in
breast cancer cell lines. Br J Cancer. 94:661–671. 2006.PubMed/NCBI
|
|
27
|
Shiozaki H, Tahara H, Oka H, Miyata M,
Kobayashi K, Tamura S, Iihara K, Doki Y, Hirano S, Takeichi M and
Mori T: Expression of immunoreactive E-cadherin adhesion molecules
in human cancers. Am J Pathol. 139:17–23. 1999.
|
|
28
|
Yang AD, Fan F, Camp ER, van Buren G, Liu
W, Somcio R, Gray MJ, Cheng H, Hoff PM and Ellis LM: Chronic
oxaliplatin resistance induces epithelial-to-mesenchymal transition
in colorectal cancer cell lines. Clin Cancer Res. 12:4147–4153.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kajiyama H, Shibata K, Terauchi M,
Yamashita M, Ino K, Nawa A and Kikkawa F: Chemoresistance to
paclitaxel induces epithelial-mesenchymal transition and enhances
metastatic potential for epithelial ovarian carcinoma cells. Int J
Oncol. 31:277–283. 2007.
|
|
30
|
Shah AN, Summy JM, Zhang J, Park SI,
Parikh NU and Gallick GE: Development and characterization of
gemcitabine-resistant pancreatic tumor cells. Ann Surg Oncol.
14:3629–3637. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Arumugam T, Ramachandran V, Fournier KF,
Wang H, Marquis L, Abbruzzese JL, Gallick GE, Logsdon CD, McConkey
DJ and Choi W: Epithelial to mesenchymal transition contributes to
drug resistance in pancreatic cancer. Cancer Res. 69:5820–5828.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: an alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hsu DS, Lan HY, Huang CH, Tai SK, Chang
SY, Tsai TL, Chang CC, Tzeng CH, Wu KJ, Kao JY and Yang MH:
Regulation of excision repair cross-complementation group 1 by
Snail contributes to cisplatin resistance in head and neck cancer.
Clin Cancer Res. 16:4561–4571. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hirohashi S and Kanai Y: Cell adhesion
system and human cancer morphogenesis. Cell Sci. 94:575–581.
2003.PubMed/NCBI
|
|
35
|
Nieto MA: The snail superfamily of
zinc-finger transcription factors. Nat Rev Mol Cell Biol.
3:155–166. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Creighton CJ, Li X, Landis M, Dixon JM,
Neumeister VM, Sjolund A, Rimm DL, Wong H, Rodriguez A,
Herschkowitz JI, et al: Residual breast cancers after conventional
therapy display mesenchymal as well as tumor-initiating features.
Proc Natl Acad Sci USA. 106:13820–13825. 2009. View Article : Google Scholar
|
|
37
|
Roesch A, Fukunaga-Kalabis M, Schmidt EC,
Zabierowski SE, Brafford PA, Vultur A, Basu D, Gimotty P, Vogt T
and Herlyn M: A temporarily distinct subpopulation of slow-cycling
melanoma cells is required for continuous tumor growth. Cell.
141:583–594. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sharma SV, Lee DY, Li B, Quinlan MP,
Takahashi F, Maheswaran S, McDermott U, Azizian N, Zou L, Fischbach
MA, et al: A chromatin-mediated reversible drug-tolerant state in
cancer cell subpopulations. Cell. 141:69–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
